Showing results (11-20 of 25) with videos related to

Sort By:
Pageof 3
European Neurology|December 14, 2011
Long-term risk of leukaemia or cardiomyopathy after mitoxantrone therapy for multiple sclerosisEoin Mulroy, Emer Joyce, Jaqueline Scott, et al.
Muscle & Nerve|October 9, 2009
Sensory ataxic neuropathy dysarthria and ophthalmoparesis (SANDO) in a sibling pair with a homozygous p.A467T POLG mutationJohn C McHugh, Roisin Lonergan, Rachel Howley, et al.
Clinical Pharmacology and Therapeutics|December 13, 2005
Pharmacogenomics of responsiveness to interferon IFN-beta treatment in multiple sclerosis: a genetic screen of 100 type I interferon-inducible genesStephen Cunningham, Colin Graham, Michael Hutchinson, et al.
Journal of Neurology, Neurosurgery, and Psychiatry|March 3, 2007
The patient knows best: significant change in the physical component of the Multiple Sclerosis Impact Scale (MSIS-29 physical)Lisa Costelloe, Killian O'Rourke, Hugh Kearney, et al.
Pharmacogenomics|July 17, 2009
Genetic polymorphisms, their allele combinations and IFN-beta treatment response in Irish multiple sclerosis patientsCatherine O'Doherty, Alexander Favorov, Shirley Heggarty, et al.
Muscle & Nerve|July 21, 2009
Phenotypic diversity associated with the mitochondrial m.8313G>A point mutationKillian O'Rourke, Mark R Buddles, Michael Farrell, et al.
Stroke|October 17, 2015
Rates and Determinants of 5-Year Outcomes After Atrial Fibrillation-Related Stroke: A Population StudyDerek T Hayden, Niamh Hannon, Elizabeth Callaly, et al.
International Journal of Stroke : Official Journal of the International Stroke Society|October 5, 2016
Why do transient ischemic attack patients have higher early stroke recurrence risk than those with ischemic stroke? Influence of patient behavior and other risk factors in the North Dublin Population Stroke StudyLayan Akijian, Danielle Ní Chróinín, Elizabeth Callaly, et al.
Pageof 3